These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
2103 related items for PubMed ID: 22000261
1. [SIB-IMRT radiotherapy given concomitantly with cisplatin for locally advanced squamous cell head and neck cancer (SCHNC). Evaluation of the early results and toxicity]. Kiprian D, Jarząbski A, Pawłowska B, Michalski W, Kawecki A. Otolaryngol Pol; 2011 Sep; 65(5 Suppl):117-25. PubMed ID: 22000261 [Abstract] [Full Text] [Related]
2. Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas: II--clinical results. Lauve A, Morris M, Schmidt-Ullrich R, Wu Q, Mohan R, Abayomi O, Buck D, Holdford D, Dawson K, Dinardo L, Reiter E. Int J Radiat Oncol Biol Phys; 2004 Oct 01; 60(2):374-87. PubMed ID: 15380569 [Abstract] [Full Text] [Related]
3. Hyperfractionated accelerated radiotherapy with concomitant integrated boost of 70-75 Gy in 5 weeks for advanced head and neck cancer. A phase I dose escalation study. Cvek J, Kubes J, Skacelikova E, Otahal B, Kominek P, Halamka M, Feltl D. Strahlenther Onkol; 2012 Aug 01; 188(8):666-70. PubMed ID: 22648405 [Abstract] [Full Text] [Related]
4. Value of intensity-modulated radiotherapy in Stage IV head-and-neck squamous cell carcinoma. Dirix P, Nuyts S. Int J Radiat Oncol Biol Phys; 2010 Dec 01; 78(5):1373-80. PubMed ID: 20362402 [Abstract] [Full Text] [Related]
13. Phase I/II study of docetaxel, cisplatin, and concomitant boost radiation for locally advanced squamous cell cancer of the head and neck. Tsao AS, Garden AS, Kies MS, Morrison W, Feng L, Lee JJ, Khuri F, Zinner R, Myers J, Papadimitrakopoulou V, Lewin J, Clayman GL, Ang KK, Glisson BS. J Clin Oncol; 2006 Sep 01; 24(25):4163-9. PubMed ID: 16943532 [Abstract] [Full Text] [Related]
14. Accelerated hyperfractionated irradiation with concomitant boost for stage II laryngeal cancer and locally advanced head and neck cancer. Ishii K, Tashiro M, Hosono M, Fukuda H, Takada Y, Kondo S, Inoue Y, Iguchi H, Kusuki M, Yamane H. Acta Otolaryngol Suppl; 2004 Oct 01; (554):62-6. PubMed ID: 15513514 [Abstract] [Full Text] [Related]
15. [Taxan induction chemotherapy and concomitant chemoradiotherapy with cisplatin in patients with locally advanced head and neck cancer--early results]. Chilimoniuk M, Olszewska E, Maksimowicz T. Pol Merkur Lekarski; 2010 Dec 01; 29(174):357-60. PubMed ID: 21298984 [Abstract] [Full Text] [Related]